Table 2.
Comparison of demographic data and clinical characteristics between RMPP and NRMPP
| NRMPP (n = 344) |
RMPP (n = 108) |
p value | |
|---|---|---|---|
| Age (month) | 35.78 ± 27.38 | 62.55 ± 35.05 | < 0.001 |
| Male (%) | 198 (57.6) | 54 (50) | 0.185 |
| Clinical profiles | |||
| Cough (%) | 311 (90.4) | 108 (100) | < 0.001 |
| Wheezing (%) | 120 (34.9) | 14 (13.0) | < 0.001 |
| Nose running (%) | 121 (35.2) | 40 (37.0) | 0.731 |
| Fever (day) | 3.39 ± 2.47 | 9.18 ± 3.55 | < 0.001 |
| Difficult feeding (%) | 12 (3.5) | 2 (1.9) | 0.530 |
| Diarrhea (%) | 31 (9.0) | 9 (8.3) | 1.000 |
| Abnormal signs of lungs (%) | 169 (49.1) | 81 (75.0) | < 0.001 |
| Hospital stay (day) | 5.97 ± 0.99 | 11.04 ± 2.72 | < 0.001 |
RMPP refractory Mycoplasma pneumoniae pneumonia, NRMPP non-refractory Mycoplasma pneumoniae pneumonia